Loading stock analysis…
Evidence Synthesis
Last synthesized: 20 Oct 2026, 08:11
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
Hipolín reported a 29.37% gross margin, accelerating from -0.42% in the last quarter.
The company's .42 marginal operating leverage also declined, down from -0.09%.
In terms of revenue growth, Hipolín's .2% year-over-year growth rate was observed. The stock's .11363462% price change was seen.
The company's daily trading volume decreased, moving from 6240 shares to 52 shares. The .9 INR close price was lower than the previous day's close price of 88 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 29.37 % | -0.42 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -0.42 % | -0.09 | ▼ |
| REVENUE_GROWTH_YOY | 59.2 % | — | - |
| PRICE_CHANGE_PERCENT | -0.114 % | — | - |
| DAILY_VOLUME | 52 shares | 6,240 | ▼ |
| CLOSE_PRICE | 87.9 INR | 88 | ▼ |
Cite this
Source: Samhati evidence synthesis for HIPOLIN (2026-10-20). Observation: Hipolín reported a 29.37% gross margin, accelerating from -0.42% in the last quarter. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/hipolin
Filing step-changes